123 related articles for article (PubMed ID: 3971391)
21. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
[TBL] [Abstract][Full Text] [Related]
22. 5-FU split dose; a phase I/II and pharmacokinetic study of a different schedule of the Nordic regimen in advanced colorectal carcinoma.
Berglund A; Carlsson G; Gustavsson B; Frödin JE; Ragnhammar P; Glimelius B
Anticancer Res; 2003; 23(2C):1789-94. PubMed ID: 12820460
[TBL] [Abstract][Full Text] [Related]
23. [Combination chemotherapy of continuous infusion 5-FU and daily low-dose CDDP in colorectal carcinoma].
Furuhata T; Hirata K; Yamamitsu S; Kimura H; Sasaki K; Hata F; Shirasaka T
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1554-8. PubMed ID: 10553412
[TBL] [Abstract][Full Text] [Related]
24. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
[TBL] [Abstract][Full Text] [Related]
25. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer].
Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Miyazaki M; Kanda Y; Amemiya K; Uchida N; Oishi T
Gan To Kagaku Ryoho; 1993 Apr; 20(5):603-9. PubMed ID: 8470917
[TBL] [Abstract][Full Text] [Related]
26. Phase I-II clinical trial of thymidine, 5-FU, and PALA given in combination.
Chiuten DF; Valdivieso M; Bedikian A; Bodey GP; Freireich EJ
Cancer Treat Rep; 1985 Jun; 69(6):611-3. PubMed ID: 4016768
[TBL] [Abstract][Full Text] [Related]
27. Treatment of metastatic colorectal carcinoma with cisplatin and 5-FU.
Shepard KV; Faintuch J; Bitran JD; Sweet DL; Robin E; Levin B
Cancer Treat Rep; 1985 Jan; 69(1):123-4. PubMed ID: 4038471
[TBL] [Abstract][Full Text] [Related]
28. 5-FU infusion in advanced colorectal cancer: a comparison of three dose schedules.
Shah A; MacDonald W; Goldie J; Gudauskas G; Brisebois B
Cancer Treat Rep; 1985; 69(7-8):739-42. PubMed ID: 4016784
[TBL] [Abstract][Full Text] [Related]
29. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
[TBL] [Abstract][Full Text] [Related]
30. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
Beerblock K; Rinaldi Y; André T; Louvet C; Raymond E; Tournigand C; Carola E; Favre R; de Gramont A; Krulik M
Cancer; 1997 Mar; 79(6):1100-5. PubMed ID: 9070486
[TBL] [Abstract][Full Text] [Related]
31. [An institution-randomized trial of 5-fluorouracil and l-leucovorin therapy given monthly versus every two months to patients with advanced colorectal carcinoma].
Hasegawa S; Akaike M; Yamamoto Y; Shiraishi R; Ozawa Y; Suzuki H; Miyazaki T; Kasahara A; Makino T; Tamura I; Tanabe H; Rino Y
Gan To Kagaku Ryoho; 2004 May; 31(5):729-33. PubMed ID: 15170981
[TBL] [Abstract][Full Text] [Related]
32. [Progress in development of chemotherapy of colorectal carcinoma].
Köhne CH
Med Klin (Munich); 1996 Apr; 91 Suppl 3():33-7. PubMed ID: 8692117
[TBL] [Abstract][Full Text] [Related]
33. A combination of 5-fluorouracil and thymidine in advanced colorectal carcinoma.
Sternberg A; Petrelli NJ; Au J; Rustum Y; Mittelman A; Creaven P
Cancer Chemother Pharmacol; 1984; 13(3):218-22. PubMed ID: 6488442
[TBL] [Abstract][Full Text] [Related]
34. Selective modulation of 5-fluorouracil action in patients with colorectal carcinoma.
Rustum YM
Chemioterapia; 1985 Oct; 4(5):377-82. PubMed ID: 3878232
[TBL] [Abstract][Full Text] [Related]
35. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA
J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492
[TBL] [Abstract][Full Text] [Related]
36. A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers.
Ardalan B; Singh G; Silberman H
J Clin Oncol; 1988 Jun; 6(6):1053-8. PubMed ID: 3373260
[TBL] [Abstract][Full Text] [Related]
37. Clinical trial of sequential N-phosphonacetyl-L-aspartate, thymidine, and 5-fluorouracil in advanced colorectal carcinoma.
O'Connell MJ; Moertel CG; Rubin J; Hahn RG; Kvols LK; Schutt AJ
J Clin Oncol; 1984 Oct; 2(10):1133-8. PubMed ID: 6491697
[TBL] [Abstract][Full Text] [Related]
38. Phase I evaluation of a biochemically designed combination: PALA, thymidine, and 5-FU.
Casper ES; Michaelson RA; Kemeny N; Martin DS; Young CW
Cancer Treat Rep; 1984 Mar; 68(3):539-41. PubMed ID: 6704982
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of sequential methotrexate and 5-FU combination in the treatment of advanced colorectal cancer.
Canobbio L; Nobile MT; Ardizzoni A; Tatarek R; Rosso R
Cancer Treat Rep; 1986 Mar; 70(3):419-20. PubMed ID: 3955557
[No Abstract] [Full Text] [Related]
40. Combination clinical trials with thymidine and fluorouracil: a phase I and clinical pharmacologic evaluation.
Woodcock TM; Martin DS; Damin LA; Kemeny NE; Young CW
Cancer; 1980 Mar; 45(5 Suppl):1135-43. PubMed ID: 7357508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
